Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Patrick Shyu ('TechLead') Says a Spot Bitcoin ETF Approval in U.S. Will Make Him Rich
-
FuboTV Gains 9% In Pre-market On Increased Q3 Revenue Outlook
-
Bitcoin (BTC/USD) Price Analysis
-
$BTC: 3.4 Million Bitcoin Addresses Buy The Dip After Price Drops Below $30,000, Data Shows
-
BTC Price Makes Slight Gains In The Wake Of First Republic Bank’s Imminent Price Fall
